Khaliq Mehwish, Ko Sungjin, Liu Yinzi, Wang Hualin, Sun Yonghua, Solnica-Krezel Lila, Shin Donghun
Department of Developmental Biology, McGowan Institute for Regenerative Medicine, Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA, USA.
Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA.
Gene Expr. 2018 Aug 22;18(3):157-170. doi: 10.3727/105221618X15242506133273. Epub 2018 Apr 24.
After liver injury, regeneration manifests as either (1) hepatocytes proliferating to restore the lost hepatocyte mass or (2) if hepatocyte proliferation is compromised, biliary epithelial cells (BECs) dedifferentiating into liver progenitor cells (LPCs), which subsequently differentiate into hepatocytes. Following pharmacogenetic ablation of hepatocytes in Tg(fabp10a:CFP-NTR) zebrafish, resulting in severe liver injury, signal transducer and activator of transcription 3 (Stat3) and its target gene and negative regulator, socs3a, were upregulated in regenerating livers. Using either Stat3 inhibitors, JSI-124 and S3I-201, or stat3 zebrafish mutants, we investigated the role of Stat3 in LPC-driven liver regeneration. Although Stat3 suppression reduced the size of regenerating livers, BEC dedifferentiation into LPCs was unaffected. However, regenerating livers displayed a delay in LPC-to-hepatocyte differentiation and a significant reduction in the number of BECs. While no difference in cell death was detected, Stat3 inhibition significantly reduced LPC proliferation. Notably, stat3 mutants phenocopied the effects of Stat3 chemical inhibitors, although the mutant phenotype was incompletely penetrant. Intriguingly, a subset of socs3a mutants also displayed a lower number of BECs in regenerating livers. We conclude that the Stat3/Socs3a pathway is necessary for the proper timing of LPC-to-hepatocyte differentiation and establishing the proper number of BECs during LPC-driven liver regeneration.
肝损伤后,再生表现为以下两种情况之一:(1)肝细胞增殖以恢复丢失的肝细胞质量;或者(2)如果肝细胞增殖受损,胆管上皮细胞(BECs)去分化为肝祖细胞(LPCs),随后肝祖细胞再分化为肝细胞。在Tg(fabp10a:CFP-NTR)斑马鱼中对肝细胞进行药物遗传学消融后,导致严重肝损伤,信号转导和转录激活因子3(Stat3)及其靶基因和负调节因子socs3a在再生肝脏中上调。使用Stat3抑制剂JSI-124和S3I-201,或stat3斑马鱼突变体,我们研究了Stat3在肝祖细胞驱动的肝脏再生中的作用。虽然抑制Stat3会减小再生肝脏的大小,但胆管上皮细胞向肝祖细胞的去分化不受影响。然而,再生肝脏在肝祖细胞向肝细胞的分化过程中出现延迟,并且胆管上皮细胞数量显著减少。虽然未检测到细胞死亡的差异,但抑制Stat3会显著降低肝祖细胞的增殖。值得注意的是,stat3突变体表现出与Stat3化学抑制剂相同的效应,尽管突变体表型不完全外显。有趣的是,一部分socs3a突变体在再生肝脏中也表现出较少的胆管上皮细胞数量。我们得出结论,Stat3/Socs3a信号通路对于肝祖细胞向肝细胞分化的正确时间以及在肝祖细胞驱动的肝脏再生过程中建立适当数量的胆管上皮细胞是必要的。